Verifying…
Home / Registered in Nigeria / Primax Eye Drops

Primax Eye Drops

NAFDAC Reg. No. B4-2293 · Drug

Registered with NAFDAC. Registration activeAs of 28 October 2026 · synced automatically from official sources.
Product
Primax Eye Drops
NAFDAC number
B4-2293
Active ingredient
Proparacaine hydrochloride
Strength
0.5%
Form
Solution/Drops
Pack size
5 mL (in LDPE white bottle)
Manufacturer
Not listed
Applicant (holder)
Lin-Kabs Pharmaceutical Limited
Approved
28 Sep 2021
Status
Inactive View on NAFDAC ↗
Registration valid to
27 Sep 2026
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Primax Eye Drops is on the NAFDAC register with an active registration (B4-2293). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Primax Eye Drops

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

ALCAINE™ ophthalmic solution is indicated for procedures in which a topical ophthalmic anesthetic is indicated: corneal anesthesia of short duration, e.g. tonometry, gonioscopy, removal of corneal foreign bodies, and for short corneal and conjunctival procedures.

How to take it and how often
  • Usual Dosage: Removal of foreign bodies and sutures, and for tonometry: 1 to 2 drops (in single instillations) in each eye before operating
  • Short Corneal and Conjunctival Procedures: 1 drop in each eye every 5 to 10 minutes for 5 to 7 doses
  • NOTE: ALCAINE™ (proparacaine hydrochloride ophthalmic solution, USP) 0.5% should be clear to straw-color
  • If the solution becomes darker, discard the solution
Children
  • Safety and effectiveness of proparacaine hydrochloride ophthalmic solution
  • In pediatric patients have been established
  • Use of proparacaine hydrochloride is supported by evidence from adequate and well-controlled studies
  • In adults and children over the age of twelve, and safety information in neonates and other
  • Pediatric patients
Older adults

No overall clinical differences in safety or effectiveness have been observed between the elderly and other adult patients.

Talk to a doctor first if

ALCAINE™ ophthalmic solution should be considered contraindicated in patients with known hypersensitivity to any of the ingredients of this preparation.

Warnings

NOT FOR INJECTION - FOR TOPICAL OPHTHALMIC USE ONLY. Prolonged use of a topical ocular anesthetic is not recommended. It may produce permanent corneal opacification with accompanying visual loss. ALCAINE™ ophthalmic solution is indicated for administration under the direct supervision of a healthcare provider. ALCAINE™ ophthalmic solution is not intended for patient self-administration.

Possible side effects

Occasional temporary stinging, burning and conjunctival redness may occur with the use of proparacaine. Corneal edema has been reported following the use of proparacaine. A rare, severe, immediate-type, apparently hyperallergic corneal reaction characterized by acute, intense and diffuse epithelial keratitis, a gray, ground glass appearance, sloughing of large areas of necrotic epithelium, corneal filaments and, sometimes, iritis with descemetitis has been reported. Allergic contact dermatitis from proparacaine with drying and fissuring of the fingertips has also been reported.

Pregnancy and breastfeeding

Pregnancy: Animal reproduction studies have not been conducted with ALCAINE ™ (proparacaine hydrochloride ophthalmic solution, USP) 0.5%. It is also not known whether proparacaine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Proparacaine hydrochloride should be administered to a pregnant woman only if clearly needed.

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2026-06-10.

Label for proparacaine hydrochloride, the active ingredient registered with NAFDAC.

Check your pack of Primax Eye Drops

Add the expiry date on your pack for a full Trust Score.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · NAFDAC · WHO alerts

About Primax Eye Drops

What is in Primax Eye Drops?

Primax Eye Drops contains Proparacaine hydrochloride (0.5%), as solution/drops, according to its NAFDAC registration record.

Is Primax Eye Drops registered with NAFDAC?

Yes. Primax Eye Drops is listed on the NAFDAC register under registration number B4-2293, and its registration is active as of 28 October 2026.

Has Primax Eye Drops been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Primax Eye Drops in our automatically synced alert list.

How can I check that my pack of Primax Eye Drops is genuine?

Run a free authenticity scan with the NAFDAC number B4-2293, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Primax Eye Drops?

Follow your prescription or the leaflet in your pack. The official label says: Usual Dosage: Removal of foreign bodies and sutures, and for tonometry: 1 to 2 drops (in single instillations) in each eye before operating. Short Corneal and Conjunctival Procedures: 1 drop in each eye every 5 to 10 minutes for 5 to 7 doses. NOTE: ALCAINE™ (proparacaine hydrochloride ophthalmic solution, USP) 0.5% should be clear to straw-color. If the solution becomes darker,…

What is Primax Eye Drops used for?

ALCAINE™ ophthalmic solution is indicated for procedures in which a topical ophthalmic anesthetic is indicated: corneal anesthesia of short duration, e.g. tonometry, gonioscopy, removal of corneal foreign bodies, and for short corneal and conjunctival procedures. (Summarised from the official U.S. FDA label for proparacaine hydrochloride. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Primax Eye Drops? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.